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AbstractsASIT MEDAL: 0311: OESTROGEN RECEPTORS AND OESOPHAGEAL CAN-
CER: A POTENTIAL THERAPEUTIC PATHWAY
Waleed Al-Khyatt 2, Cristina Tufarelli 1, Raheela Khan 1, Syed Iftikhar 2.
1 School of Graduate Entry Medicine and Health, University of Nottingham,
Royal Derby Hospital, Derby, UK; 2Division of Surgery, Royal Derby Hospital,
Derby, UK.
Introduction: Oestrogen receptors (ER) have a well-established link in the
initiation, progression and response to treatment of some cancers. Little is
known, however, about the signiﬁcance of ER as therapeutic biomarkers in
oesophageal cancer (OC).
Methods: Effects of ER modulators on proliferation in OE33 and OE19 OC
cells was evaluated. ERa and ERb expression in paired normal and tumour
oesophageal samples (n ¼ 34) was performed using RT-qPCR. Correlation
between ERmRNA expression and clinico-pathological features for OC was
determined.
Results: There was a signiﬁcant dose dependent inhibition of proliferation
in OE33 and OE19 OC cells by a highly selective ERa antagonist (MPP) and
an ERb speciﬁc antagonist (PHTPP) (p <0.05). RT-qPCR analysis revealed
that ERa and ERb mRNA expression was signiﬁcantly higher (p<0.05) in
tumour tissues relative to their paired normal mucosa. Expression of ERa
and ERb in tumour samples correlated inversely with survival outcome
(p<0.05). Up-regulation of ERa correlated with higher pathological T stage
(p<0.05) and lymph node metastasis (p<0.05), while ERb up-regulation
correlated with positive vascular invasion (p<0.05).
Conclusions: Our ﬁndings indicate a role for ER in the biological behaviour
of OC. Hence, the ER system may provide an additional novel target for the
treatment of OC.
ASIT MEDAL: 0853: ASIT ANSELL MEDAL PRIZEWINNER: HUMANAMNI-
OTIC EPITHELIAL CELLS MODULATE ALLOREACTIVE T-CELL ACTIVITY: A
POTENTIAL ADJUNCT TO CELLULAR TRANSPLANTATION
Khalid Qureshi, Jou-Ann Lee, Michelle Paget,
Hilary Murray, Richard Downing. The Islet Research Laboratory,
Worcestershire, UK.
Introduction: Human amniotic epithelial cells (AEC) display immuno-
modulatory properties. We have previously demonstrated that bio-engi-
neered transplantable constructs formed by co-culturing human islets and
AEC (islet:AEC) exhibit markedly reduced immunogenicity in contact with
peripheral blood mononuclear cells (PBMC) compared to unmodiﬁedislets, which is likely to reduce their vulnerability to graft rejection. To
extend these ﬁndings we now provide evidence that distinct T-cell sub-
populations, implicated in allograft destruction, are targets for AEC
immunomodulation.
Methods: Magnetic assisted cell sorted CD4+ and CD8+ T-cells were
cultured alone or in contact with human AEC, islets or islet:AEC constructs,
using CD3/CD28 to induce physiological activation and expansion. The
degree of allo-reactivity viz. T-cell proliferation was assessed by chem-
iluminescence assay.
Results: CD4+ and CD8+ T-cell proliferation was responsive to AEC co-
culture with CD3/CD28 activation being dose-dependently reduced
(p<0.05). CD4+ and CD8+ proliferation was also markedly attenuated on
contact with islet:AEC constructs compared to that observed with un-
modiﬁed islets (p < 0.05).
Conclusion: T-cells that are known to mediate allograft rejection in cell
transplantation are modulated by AEC. AEC may therefore serve as an
adjunct in cell transplantation, reducing the requirement for chronic sys-
temic immunosuppression and promoting long-term graft survival.ASIT MEDAL: 0921: PROSPECTIVE STUDY TO ASSESS TUMOUR NECROSIS
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Aim: Tumour necrosis factor alpha (TNF-a) is elevated in inﬂammatory
bowel disease enterocutaneous ﬁstula (IBD ECF). No study has assessed the
level in non-IBD ECF. The aim of this study was to assess the inﬂammatory
activity, with a particular emphasis on TNF-a in non-IBD ECF when
compared with control small bowel tissue.
Methods: Tissue biopsies were obtained from ECF at operation from non-
IBD patients and from normal control patients. After overnight culture,
intracellular staining was performed using monensin to assess on-going
production of TNF-a. Data was acquired using FACS Canto II. Unpaired
Student's t-test was used to compare variables between groups.
Results: The on-going production of TNF-a from dendritic cells (p ¼
0.0007), putative monocyte and B cell populations (p ¼ 0.04) and CD3+ T
cells (p ¼ 0.04) was signiﬁcantly higher than that from control tissue.
